NDC 14403-3400-01 - Liraglutide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 14403-3400
- Requested NDC
- 14403-3400-01
- Package NDCs from labels
- 14403-3400-1, 14403-3400-2, 14403-3400-3, 14403-3400-01
- Manufacturer
- Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-06-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 4 | |
| 14403-3400-2 | Liraglutide | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 4 | |
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 3 | |
| 14403-3400-3 | Liraglutide | 3 in 1 CARTON | INJECTION, SOLUTION | 3 | 3 | |
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 4 | Current NDC, 2 package rows | 20241225_1a372465-d56b-2b80-e063-6394a90a3304.zip |
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 3 | Current NDC, 2 package rows | 20241225_1a36f43f-d734-97cc-e063-6294a90ae0da.zip |
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 1 | Current NDC, 1 package rows | 20241224_1a36b801-41e2-2eed-e063-6294a90a6f27.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Victoza | LIRAGLUTIDE | A-S Medication Solutions | 1d18f106-0584-4fee-97ab-32771a64b809 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Victoza | LIRAGLUTIDE | A-S Medication Solutions | 35e613e3-7aae-4152-b827-99d1ee7841be | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.